Fibroma epidemiology and demographics

Revision as of 05:19, 7 March 2016 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Fibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Screening

Differentiating Fibroma from other Diseases

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Fibroma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibroma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibroma epidemiology and demographics

CDC on Fibroma epidemiology and demographics

Fibroma epidemiology and demographics in the news

Blogs on Fibroma epidemiology and demographics

Directions to Hospitals Treating Fibroma

Risk calculators and risk factors for Fibroma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Patients of all age groups may develop fibromas. However, the majority of fibromas are observed in adults. Fibromas usually affects men and women equally, however certain fibromas may show gender predilection. Fibromas are most often observed in adults, but they may occur in individuals of any age and either sex.

Epidemiology and Demographics

Non-ossifying Fibroma

Prevalence

The prevalence of non-ossifying fibroma is estimated to be 30-40 % of all normal children.

Incidence

Age

Non-ossifying fibromas are the most common fibrous bony lesions in children and adolescents, with a peak incidence at 10-15 years old. Non-ossifying fibromas are not seen beyond the age of 30 years, as they spontaneously heal.

Gender

Males are more commonly affected with non-ossifying fibromas than females. The male to female ratio is approximately 2 to 1.

Race

Desmoplastic Fibroma

Incidence

The incidence of fibroma is approximately 0.3%.

Age

The median age at presentation is 21 years.

Gender

Desmoplastic fibromas affects men and women equally.

Ovarian Fibroma

Age

Patients of all age groups may develop ovarian fibroma. However, they are most frequently seen in middle-aged women.

Ossifying Fibroma

Age

Ossifying fibromas most frequently occur in young children (less than 10 years of age).

Chondromyxoid Fibroma

Gender

Chondromyxoid fibromas affects men and women equally.

Age

Patients of all age groups may develop chondromyxoid fibroma. However, they are most frequently seen in second and third decades. Approximately 75% of cases occur before the age of 30 years.

Cardiac Fibroma

Age

Cardiac fibromas primarily affects children, the majority of cases are detected in infants or in utero. They are the second most common benign primary cardiac tumour in children after cardiac rhabdomyoma and second commonest fetal cardiac tumour.

Pleural Fibromas

Gender

Cardiac fibromas affects men and women equally.

Age

Cardiac fibromas usually presents in the 6th to 7th decades.

Cemento-ossifying Fibroma

Age

Cemento-ossifying fibromas are most frequently diagnosed during the third and fourth decades. Occasionally, they are identified in children, in which case they are a more aggressive variant and are known as juvenile aggressive cemento-ossifying fibromas.

Gender

Females are more commonly affected with cemento-ossifying fibromas than males. The female to male ratio is approximately 2-5 to 1.

Oral Fibroma

Age

Patients of all age groups may develop oral fibromas. However, they are most commonly seen in older adults. It affects 1-2% of adults.

Gender

Oral fibromas affect men and women equally.

Giant cell fibroma

Age

The majority of cases of giant cell fibroma are diagnosed in persons aged 10-30 years.

Gender

Giant cell fibromas affects men and women equally. Most cases are diagnosed in persons aged 10-30 years.

Elastofibroma

Age

Elastofibroma commonly affects individuals older than 50 years of age.

Gender

Females are more commonly affected with elastofibroma than males.

References

Template:WH Template:WS